I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
NCT00590096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1380
Last updated 2009-08-25
Summary
I-123-MIBG is used to image patients with neuroblastoma, pheochromocytoma and other neural crest tumors
Conditions
- Neuroblastoma
- Pheochromocytoma
Sponsors & Collaborators
-
University of Cincinnati
collaborator OTHER -
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Michael J Gelfand, M.D. · Children's Hospital Medical Center, Cincinnati
Eligibility
- Min Age
- 2 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-01-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
More Related Trials
-
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
NCT02160925 ·Status: COMPLETED ·Phase: NA
-
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT00147056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
NCT06014905 ·Status: RECRUITING ·Phase: PHASE1
-
Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
NCT00005084 ·Status: UNKNOWN ·Phase: PHASE2
-
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
NCT05565326 ·Status: RECRUITING
-
Development and Validation of Advanced MRI Methods for Clinical Applications
NCT03264300 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas
NCT04469244 ·Status: COMPLETED
-
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
NCT03952598 ·Status: SUSPENDED ·Phase: PHASE2
-
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
NCT02095353 ·Status: TERMINATED
-
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NCT07119294 ·Status: RECRUITING ·Phase: NA
-
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
NCT00187226 ·Status: COMPLETED ·Phase: PHASE2
-
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
NCT00005790 ·Status: WITHDRAWN ·Phase: NA
-
AI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256 ·Status: RECRUITING
-
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
NCT02540135 ·Status: WITHDRAWN ·Phase: NA
-
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
NCT01800032 ·Status: COMPLETED
-
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
NCT01604590 ·Status: COMPLETED
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Blood Flow MRI for Monitoring Brain Tumors
NCT01538264 ·Status: ACTIVE_NOT_RECRUITING
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
NCT00756106 ·Status: TERMINATED ·Phase: NA
-
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
NCT01106794 ·Status: RECRUITING
-
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT00005082 ·Status: COMPLETED ·Phase: NA
-
Rare Embryonal Tumors of the Central Nervous System: International Registry
NCT05711992 ·Status: RECRUITING
-
68Ga-DOTATATE Neuroblastoma Imaging Pilot
NCT04559217 ·Status: RECRUITING ·Phase: PHASE2
-
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
NCT03101813 ·Status: RECRUITING